-
1481
-
1482
-
1483
A Meta-Analysis of GBA-Related Clinical Symptoms in Parkinson’s Disease
Published 2018-01-01Get full text
Article -
1484
-
1485
-
1486
Cerebrospinal fluid‐specific oligoclonal bands in dogs with idiopathic epilepsy
Published 2025-01-01Get full text
Article -
1487
CCL-2 and CXCL-8: Potential Prognostic Biomarkers of Acute Kidney Injury after a Bothrops atrox Snakebite
Published 2022-01-01Get full text
Article -
1488
-
1489
-
1490
The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors
Published 2025-01-01“…Yujing Xin,1 Ning Liu,2 Gang Peng,3 Xiaoyu Huang,3 Xiaojing Cao,3 Xiang Zhou3 1Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People’s Republic of China; 2School of Software, Shandong University, Jinan, Shandong, 250101, People’s Republic of China; 3National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of ChinaCorrespondence: Xiang Zhou, Email zhou.xiang@yeah.netPurpose: To investigate the prognostic value of inflammatory indexes based on peripheral blood cells in unresectable hepatocellular carcinoma (HCC) patients treated with Lenvatinib combined with PD-1 inhibitors.Methods: This study retrospectively collected baseline inflammatory indexes from HCC patients received Lenvatinib and PD-1 inhibitor-based combination therapy at the Cancer Hospital of the Chinese Academy of Medical Sciences between October 2018 and October 2021. …”
Get full text
Article -
1491
-
1492
-
1493
-
1494
-
1495
Burnout in Healthcare Professionals during Covid-19 Crisis
Published 2024-07-01Get full text
Article -
1496
-
1497
-
1498
-
1499
Thirty-year trends of anxiety disorders among adolescents based on the 2019 Global Burden of Disease Study
Published 2024-04-01Get full text
Article -
1500